Most Recent
An appeals court has found US drug maker Cosette could not rely on sales performance figures to justify its termination of a $672 million merger agreement with Mayne Pharma Group.
Insurer IAG has argued Greensill investor White Oak failed to verify the existence of $140 million in receivables for fear the deal wouldn't go ahead -- conduct, it says, that was “redolent of a deal that is too good to be true”.
Insurance underwriter Tokio Marine has denied misleading US investment firm White Oak by staying silent on alleged issues with an IAG policy keeping Greensill's supply chain financing business operating.
After baulking at paying for their Rolls-Royce defence, Greensill investor White Oak has been ordered to pay a total of $13 million in security to insurers IAG, Tokio Marine and BCC for their costs of a 35-day trial.
Greensill Capital's founder expressed "shock" in 2020 when concerns emerged over the validity of an IAG policy keeping his financing business afloat, telling underwriter BCC's then managing director the issue needed to be kept quiet, a court has heard.
IAG and Tokio Marine kept their concerns about the validity of Greensill Capital's 2019 trade credit insurance policy confidential, even as they must have known the supply chain financier was using the policy to attract investors, a trial court has heard.
Investor White Oak on Tuesday fought back against a push by IAG and Tokio Marine for over $15 million in security on the eve of trial in its case over the collapse of Greensill Capital, saying the insurers' Rolls Royce approach was unreasonable now that the bulk of the $7 billion litigation had settled.
Cosette wants to strike out Mayne Pharma’s claim for damages over their thwarted $672 million merger, arguing it creates a multiplicity of cases in which various shareholder groups' interests conflict.
A KPMG partner who resigned in the wake of the firm's leaks scandal in May has defended his auditing of now defunct steelmaker Arrium, telling a court that inconsistencies were resolved through talks with management.
The former chairman of collapsed Arrium has denied that his purchase of 750,000 shares was aimed at showing confidence in the company, attributing his purchase to a personal policy.